Cargando…

Evaluation of Kappa Index as a Tool in the Diagnosis of Multiple Sclerosis: Implementation in Routine Screening Procedure

Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system. Previous studies have shown that cerebrospinal fluid (CSF) kappa free light chains (K-FLCs) may have a role in MS diagnosis. In this regard, the kappa index (K-Index) has demonstrated higher sensitivity,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanz Diaz, Carmen Teresa, de las Heras Flórez, Silvia, Carretero Perez, Mercedes, Hernández Pérez, Miguel Ángel, Martín García, Vicente
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386692/
https://www.ncbi.nlm.nih.gov/pubmed/34456842
http://dx.doi.org/10.3389/fneur.2021.676527
_version_ 1783742303860424704
author Sanz Diaz, Carmen Teresa
de las Heras Flórez, Silvia
Carretero Perez, Mercedes
Hernández Pérez, Miguel Ángel
Martín García, Vicente
author_facet Sanz Diaz, Carmen Teresa
de las Heras Flórez, Silvia
Carretero Perez, Mercedes
Hernández Pérez, Miguel Ángel
Martín García, Vicente
author_sort Sanz Diaz, Carmen Teresa
collection PubMed
description Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system. Previous studies have shown that cerebrospinal fluid (CSF) kappa free light chains (K-FLCs) may have a role in MS diagnosis. In this regard, the kappa index (K-Index) has demonstrated higher sensitivity, and slightly lower specificity than oligoclonal bands (OCBs), the gold standard for the detection of intrathecal immunoglobulin synthesis, a feature of MS. Here, we evaluated the performance of the K-Index (K-Index = CSF/serum K-FLC divided by CSF/serum albumin) for the differential diagnosis of MS in a cohort of patients with suspected MS. K-FLCs were quantitatively measured in parallel serum and CSF samples by turbidimetry (Freelite Mx reagent on an Optilite system, The Binding Site Group Ltd). From 160 (63.4%) of a total of 252 patients who had K-FLC in CSF <0.03 mg/dl, below the sensitivity limit of the technique, only one had a diagnosis of MS. However, the absence of OCB in this same patient suggested no synthesis of intrathecal immunoglobulin. Globally, MS patients presented significantly higher K-Index levels than patients without an MS diagnosis (66.96 vs. 0.025, respectively; p < 0.0001). In agreement, patients with positive OCB testing also exhibited higher K-Index levels than patients negative for OCB (65.02 vs. 0.024, respectively; p < 0.0001). An optimal K-Index cutoff of 3.045 was defined by receiver operating characteristic (ROC) analysis for screening suspected MS, achieving a higher diagnostic sensitivity and slightly lower specificity than OCB (Sens. 0.9778 and Spec. 0.8629 vs. Sens. 0.8889 and Spec. 0.9086, respectively). A previously reported K-Index cutoff of 6.6 also showed good diagnostic performance (Sens. 0.9333; Spec. 0.8731), validating its power as a diagnostic biomarker for MS. Finally, a time- and cost-effective algorithm for MS screening is proposed that would offer an initial rapid evaluation of the intrathecal immunoglobulin synthesis through the K-FLC in CSF and K-Index analysis, followed by reflexing OCB testing that may be ordered more selectively.
format Online
Article
Text
id pubmed-8386692
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83866922021-08-26 Evaluation of Kappa Index as a Tool in the Diagnosis of Multiple Sclerosis: Implementation in Routine Screening Procedure Sanz Diaz, Carmen Teresa de las Heras Flórez, Silvia Carretero Perez, Mercedes Hernández Pérez, Miguel Ángel Martín García, Vicente Front Neurol Neurology Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system. Previous studies have shown that cerebrospinal fluid (CSF) kappa free light chains (K-FLCs) may have a role in MS diagnosis. In this regard, the kappa index (K-Index) has demonstrated higher sensitivity, and slightly lower specificity than oligoclonal bands (OCBs), the gold standard for the detection of intrathecal immunoglobulin synthesis, a feature of MS. Here, we evaluated the performance of the K-Index (K-Index = CSF/serum K-FLC divided by CSF/serum albumin) for the differential diagnosis of MS in a cohort of patients with suspected MS. K-FLCs were quantitatively measured in parallel serum and CSF samples by turbidimetry (Freelite Mx reagent on an Optilite system, The Binding Site Group Ltd). From 160 (63.4%) of a total of 252 patients who had K-FLC in CSF <0.03 mg/dl, below the sensitivity limit of the technique, only one had a diagnosis of MS. However, the absence of OCB in this same patient suggested no synthesis of intrathecal immunoglobulin. Globally, MS patients presented significantly higher K-Index levels than patients without an MS diagnosis (66.96 vs. 0.025, respectively; p < 0.0001). In agreement, patients with positive OCB testing also exhibited higher K-Index levels than patients negative for OCB (65.02 vs. 0.024, respectively; p < 0.0001). An optimal K-Index cutoff of 3.045 was defined by receiver operating characteristic (ROC) analysis for screening suspected MS, achieving a higher diagnostic sensitivity and slightly lower specificity than OCB (Sens. 0.9778 and Spec. 0.8629 vs. Sens. 0.8889 and Spec. 0.9086, respectively). A previously reported K-Index cutoff of 6.6 also showed good diagnostic performance (Sens. 0.9333; Spec. 0.8731), validating its power as a diagnostic biomarker for MS. Finally, a time- and cost-effective algorithm for MS screening is proposed that would offer an initial rapid evaluation of the intrathecal immunoglobulin synthesis through the K-FLC in CSF and K-Index analysis, followed by reflexing OCB testing that may be ordered more selectively. Frontiers Media S.A. 2021-08-11 /pmc/articles/PMC8386692/ /pubmed/34456842 http://dx.doi.org/10.3389/fneur.2021.676527 Text en Copyright © 2021 Sanz Diaz, de las Heras Flórez, Carretero Perez, Hernández Pérez and Martín García. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Sanz Diaz, Carmen Teresa
de las Heras Flórez, Silvia
Carretero Perez, Mercedes
Hernández Pérez, Miguel Ángel
Martín García, Vicente
Evaluation of Kappa Index as a Tool in the Diagnosis of Multiple Sclerosis: Implementation in Routine Screening Procedure
title Evaluation of Kappa Index as a Tool in the Diagnosis of Multiple Sclerosis: Implementation in Routine Screening Procedure
title_full Evaluation of Kappa Index as a Tool in the Diagnosis of Multiple Sclerosis: Implementation in Routine Screening Procedure
title_fullStr Evaluation of Kappa Index as a Tool in the Diagnosis of Multiple Sclerosis: Implementation in Routine Screening Procedure
title_full_unstemmed Evaluation of Kappa Index as a Tool in the Diagnosis of Multiple Sclerosis: Implementation in Routine Screening Procedure
title_short Evaluation of Kappa Index as a Tool in the Diagnosis of Multiple Sclerosis: Implementation in Routine Screening Procedure
title_sort evaluation of kappa index as a tool in the diagnosis of multiple sclerosis: implementation in routine screening procedure
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386692/
https://www.ncbi.nlm.nih.gov/pubmed/34456842
http://dx.doi.org/10.3389/fneur.2021.676527
work_keys_str_mv AT sanzdiazcarmenteresa evaluationofkappaindexasatoolinthediagnosisofmultiplesclerosisimplementationinroutinescreeningprocedure
AT delasherasflorezsilvia evaluationofkappaindexasatoolinthediagnosisofmultiplesclerosisimplementationinroutinescreeningprocedure
AT carreteroperezmercedes evaluationofkappaindexasatoolinthediagnosisofmultiplesclerosisimplementationinroutinescreeningprocedure
AT hernandezperezmiguelangel evaluationofkappaindexasatoolinthediagnosisofmultiplesclerosisimplementationinroutinescreeningprocedure
AT martingarciavicente evaluationofkappaindexasatoolinthediagnosisofmultiplesclerosisimplementationinroutinescreeningprocedure